Pharmacist support 24/7

Select Language

Keytruda Pembrolizumab 100mg Injection

Manufacturer: MSD PHARMACEUTICALS PVT LTD

Salt: PEMBROLIZUMAB 100MG

Category: Anti-Cancer

Price: $2085

Availability: In Stock

Keytruda (pembrolizumab) 100mg injection is a PD-1–blocking immunotherapy used with the immune system to treat certain cancers. It targets the PD-1 pathway to help T cells recognize tumor cells. Use only under oncology supervision; prescribing information applies.
Keytruda is indicated for the treatment of various cancers affecting different parts of the body, including stage III melanoma, advanced cervical cancer, and renal cell carcinoma. It is also used for advanced or metastatic urothelial cancer, often in combination with enfortumab vedotin or platinum based chemotherapy. It has shown significant efficacy in treating cell lung cancer (NSCLC) and cutaneous squamous cell carcinoma.
In Stock
Keytruda Pembrolizumab 100mg Injection
(4.8/5) 124 reviews
Medically Reviewed
Pharmacist Verified

Keytruda Pembrolizumab 100mg Injection

ManufacturerMSD PHARMACEUTICALS PVT LTD
Salt CompositionPEMBROLIZUMAB 100MG
Anti Cancer
Sale Price
$2085$2418.60
16% OFF
1

Product Information

What is Keytruda Pembrolizumab 100mg Injection?

Keytruda (pembrolizumab) 100mg injection is a PD-1–blocking immunotherapy used with the immune system to treat certain cancers. It targets the PD-1 pathway to help T cells recognize tumor cells. Use only under oncology supervision; prescribing information applies.

Indications for Keytruda Pembrolizumab 100mg Injection

Keytruda is indicated for the treatment of various cancers affecting different parts of the body, including stage III melanoma, advanced cervical cancer, and renal cell carcinoma. It is also used for advanced or metastatic urothelial cancer, often in combination with enfortumab vedotin or platinum based chemotherapy. It has shown significant efficacy in treating cell lung cancer (NSCLC) and cutaneous squamous cell carcinoma.

Therapeutic Effects of Keytruda Pembrolizumab 100mg Injection

The therapeutic effect of pembrolizumab is the activation of the immune system to identify and attack cancer cells in the body. It is a type of immunotherapy drug that blocks a protein called PD-1 present in immune cells, which allows the immune system to identify and attack cancer cells more effectively. By doing so, this drug can help slow or inhibit the spread and growth of cancer cells in the body.

How to consume Keytruda Pembrolizumab 100mg Injection

Keytruda 100mg Injection is a medication that is administered by a healthcare professional, typically in a hospital or clinic setting. The medication is given as an intravenous (IV) infusion. The dosage and frequency will depend on the type and stage of the cancer, as well as the patient's overall health and response to the medication. The medication is typically given every three to four weeks, and the number of treatment cycles varies with the type and staging of cancer and the patient's response to the drug. During the infusion, the patient will be monitored by a healthcare professional for any potential side effects or reactions to the medication.

Side Effects of Keytruda Pembrolizumab 100mg Injection

Serious

Pneumonitis (inflammation of the lungs).

Hepatitis (inflammation of the liver).

Colitis (inflammation of the colon).

Hypothyroidism or hyperthyroidism.

Adrenal insufficiency (decreased adrenal function).

Type 1 diabetes.


Common

Fatigue

Nausea

Loss of appetite

Diarrhea or constipation

Skin rash or itching

Headache

Muscle or joint pain

Cough or shortness of breath

Fever or chills

Low blood cell counts

Drug Interactions

Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Keytruda 100mg Injection and reduce effectiveness by causing undesirable side effects.

Storage & Handling

  • Keytruda 100mg Injection should be kept refrigerated between 2°C and 8°C (36°F to 46°F).
  • This medication should be protected from light and kept in its original packaging until the time of use.
  • Keep it out of reach from children and pets.

Expert Advice

Patients undergoing treatment should monitor for side effects like dry eye or changes in white blood cells. In some cases, it may be used following a stem cell transplant. Always discuss the full clinical profile with your oncologist.

Worldwide Shipping & Delivery

We provide specialized tracked delivery for Keytruda Pembrolizumab 100mg Injection to multiple countries across the globe. Our logistics network ensures temperature-controlled handling for sensitive oncology medications.

  • USA Shipping
  • UK Delivery
  • UAE & Middle East
  • Germany & EU
  • Australia
  • Canada

Professional Safety Guidelines for Keytruda Pembrolizumab 100mg Injection

Pregnancy
Pregnancy
Unsafe

If women is taking then it is a potential risk of harm to a nursing infant. Breastfeeding women should discuss the potential risks and benefits of the medication with their healthcare provider before starting treatment.

BreastFeeding
BreastFeeding
Unsafe

Keytruda 100mg Injection is unsafe for a developing fetus, and it is not recommended for use during pregnancy.

Liver
Liver
Consult your doctor

Keytruda 100 mg Injection can affect liver function, and patients with pre-existing liver disease or abnormalities may be at increased risk of liver damage. Patients should tell their healthcare provider if they have a history of liver disease or abnormal liver function tests because it is unsafe to use this drug with pre-existing liver disease.

Lungs
Lungs
Consult your doctor

Keytruda 100mg Injection has been associated with mild lung-related side effects, although these are relatively uncommon. You should consult the doctor if you have any lung diseases before starting the treatment.

Alcohol
Alcohol
Unsafe

It is generally recommended that patients taking Keytruda 100mg Injections avoid or limit their alcohol intake, as alcohol increases the risk of liver damage and exacerbates any liver-related side effects.

Driving
Driving
Unsafe

Patients receiving Keytruda 100mg Injection should avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision, impairing a patient's ability to drive or operate machinery safely.

Similar Medications

View All